INMUNE BIO INC (INMB) Stock Income Statement
NASDAQ:INMB - Nasdaq - US45782T1051 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 50.00K | 14.00K | 155.00K | 370.00K | 180.00K | |||
| Operating Expenses | 41.57M | 42.65M | 29.90M | 26.33M | 29.33M | |||
| Research and Development | 32.11M | 33.17M | 20.27M | 17.07M | 20.54M | |||
| Selling, General, and Administrative Expenses | 9.46M | 9.48M | 9.62M | 9.26M | 8.79M | |||
| Operating Income | -41.52M | -42.63M | -29.74M | -25.95M | -29.15M | |||
| Interest Income/Expense | N/A | -789.00K | -2.28M | -2.01M | -990.00K | |||
| Other Income/Expense | 1.16M | 1.34M | 2.01M | 670.00K | -200.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -40.80M | -42.08M | -30.01M | -27.30M | -30.34M | |||
| Net Income | -40.80M | -42.08M | -30.01M | -27.30M | -30.34M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.95 | -2.11 | -1.67 | -1.52 | -1.88 | |||
| Non GAAP EPS | -1.93 | -2.11 | -1.67 | -1.52 | -1.86 | |||
| Statistics | ||||||||
| Profit Margin | -81592.00% | -300585.71% | -19360.00% | -7378.38% | -16855.56% | |||
| Operating Profit Margin | -83046.00% | -304535.71% | -19187.74% | -7013.51% | -16194.44% | |||
All data in USD